Gene · 3980
Papers1,941
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 1,941
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cyclin-dependent kinases-based synthetic lethality: Evidence, concept, and strategy. | Acta Pharm Sin B | 2021 | 34589394 | PubTator, text mining | PubMed |
| Polymerase θ Coordinates Multiple Intrinsic Enzymatic Activities during DNA Repair. | Genes (Basel) | 2021 | 34573292 | PubTator, text mining | PubMed |
| Precision Oncology with Drugs Targeting the Replication Stress, ATR, and Schlafen 11. | Cancers (Basel) | 2021 | 34572827 | PubTator, text mining | PubMed |
| Corrigendum to: Myopathic mitochondrial DNA depletion syndrome associated with biallelic variants in LIG3. | Brain | 2021 | 34564719 | PubTator, text mining | PubMed |
| TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors. | Pharmacol Res | 2021 | 34560251 | PubTator, text mining | PubMed |
| Loss of nuclear DNA ligase III reverts PARP inhibitor resistance in BRCA1/53BP1 double-deficient cells by exposing ssDNA gaps. | Mol Cell | 2021 | 34555355 | PubTator, text mining | PubMed |
| Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection. | Onco Targets Ther | 2021 | 34552338 | PubTator, text mining | PubMed |
| Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia. | Cell Rep | 2021 | 34551306 | PubTator, text mining | PubMed |
| Structure-based virtual screening and molecular dynamics simulation studies to discover new SARS-CoV-2 main protease inhibitors. | Sci Afr | 2021 | 34541426 | PubTator, text mining | PubMed |
| PARP1 as a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome. | Blood Adv | 2021 | 34529761 | PubTator, text mining | PubMed |
| Versatile cell-based assay for measuring DNA alkylation damage and its repair. | Sci Rep | 2021 | 34526526 | PubTator, text mining | PubMed |
| NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancers. | Sci Adv | 2021 | 34524841 | PubTator, text mining | PubMed |
| Deconvolution of multiplexed transcriptional responses to wood smoke particles defines rapid aryl hydrocarbon receptor signaling dynamics. | J Biol Chem | 2021 | 34520756 | PubTator, text mining | PubMed |
| Sex-specific differences in DNA double-strand break repair of cycling human lymphocytes during aging. | Aging (Albany NY) | 2021 | 34506302 | PubTator, text mining | PubMed |
Pim kinase inhibitor co-treatment decreases alternative non-homologous end-joining DNA repair and genomic instability induced by topoisomerase 2 inhibitors in cells with FLT3 internal tandem duplication. | Oncotarget | 2021 | 34504649 | PubTator, text mining | PubMed |
| Investigation on the Effects of MXene and β-Nucleating Agent on the Crystallization Behavior of Isotactic Polypropylene. | Polymers (Basel) | 2021 | 34502971 | PubTator, text mining | PubMed |
| DNA polymerase θ promotes CAG•CTG repeat expansions in Huntington's disease via insertion sequences of its catalytic domain. | J Biol Chem | 2021 | 34473992 | PubTator, text mining | PubMed |
| Targeting protein-protein interactions in the DNA damage response pathways for cancer chemotherapy. | RSC Chem Biol | 2021 | 34458830 | PubTator, text mining | PubMed |
| DNA adduct formation and reduced EIF4A3expression contributes to benzo[a]pyrene-induced DNA damage in human bronchial epithelial BEAS-2B cells. | Toxicol Lett | 2021 | 34454013 | PubTator, text mining | PubMed |
| Mechanism of Hepatitis B Virus cccDNA Formation. | Viruses | 2021 | 34452329 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3980/papers?page=25